Actinogen trial using intended commercial Xanamem tablet formulation confirms target exposures in fed and fasted statesLikeFollowShareRead full article via PR Newswirehttps://www.prnewswire.com/news-releases/actinogen-trial-using-intended-com...Share your feedbackQuestions (0)Post questionYour question will be sent privately to Actinogen. The company may choose to make this question public.Start the conversationAsk Actinogen a question about this update.DiscoverShare your feedbackDiscover
